October 2007 |
|
Grassley delves further into FDA review of foreign-made pharmaceuticals
|
|
Sen. Grassley seeks transparency in FDA review of heart health risks with diabetes drug
|
|
Grassley Releases Participant List for Non-profit Hospital Roundtable
|
|
Sen. Grassley’s comment on the House vote on a second SCHIP compromise bill
|
|
“Mother of Tax Bills” Could Bring Mother Lode of Economic Trouble
|
|
Sen. Grassley comments on FDA letter to drug maker about flawed Ketek study
|
|
Grassley Announces Roundtable on Staff Discussion Draft on Non-profit Hospitals
|
|
Grassley: House Tax Proposal Could Undermine U.S. Companies’ Competitiveness
|
|
Grassley, Specter Introduce Transparency in Medical Device Pricing Act
|
|
Grassley: Treasury Analysis Shows 50 Million Taxpayers Could Get Hit with AMT-related Filing Fiasco
|
|
Grassley, Baucus ask about oversight and operation of nursing homes taken over by large private investment firms
|
|
Grassley, McCrery Seek Treasury Response on Taxpayer Impact of Delayed AMT Relief
|
|
Grassley Urges Export-Import Bank to Better Screen Funding Projects
|
|
Grassley, Roberts: CHIP Compromise Bill Does Not Extend Coverage to Families With $83,000 Incomes; HHS Retains Authority to Deny State Plan Amendments Inconsistent With CHIP
|
|
Grassley: Report Shows Export-Import Bank is Not Screening Enough to Prevent Funding Projects that Hurt U.S. Industry, Including Ethanol
|